000022962 001__ 22962
000022962 005__ 20201217130352.0
000022962 0247_ $$2DOI$$a10.1128/AEM.69.5.2521-2532.2003
000022962 0247_ $$2WOS$$aWOS:000182808300012
000022962 0247_ $$2Handle$$a2128/2407
000022962 0247_ $$2altmetric$$aaltmetric:21808622
000022962 0247_ $$2pmid$$apmid:12732517
000022962 037__ $$aPreJuSER-22962
000022962 041__ $$aeng
000022962 082__ $$a570
000022962 084__ $$2WoS$$aBiotechnology & Applied Microbiology
000022962 084__ $$2WoS$$aMicrobiology
000022962 1001_ $$0P:(DE-Juel1)VDB8475$$aLange, C.$$b0$$uFZJ
000022962 245__ $$aGlobal expression profiling and physiological characterization of Corynebacterium glutamicum grown in the presence of L-valine
000022962 260__ $$aWashington, DC [u.a.]$$bSoc.$$c2003
000022962 300__ $$a2521 - 2532
000022962 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000022962 3367_ $$2DataCite$$aOutput Types/Journal article
000022962 3367_ $$00$$2EndNote$$aJournal Article
000022962 3367_ $$2BibTeX$$aARTICLE
000022962 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000022962 3367_ $$2DRIVER$$aarticle
000022962 440_0 $$08561$$aApplied and Environmental Microbiology$$v69$$x0099-2240
000022962 500__ $$aRecord converted from VDB: 12.11.2012
000022962 520__ $$aAddition of L-valine (50 to 200 mM) to glucose minimal medium had no effect on the growth of wild-type Corynebacterium glutamicum ATCC 13032 but inhibited the growth of the derived valine production strain VAL1 [13032 DeltailvA DeltapanBC(pJCilvBNCD)] in a concentration-dependent manner. In order to explore this strain-specific valine effect, genomewide expression profiling was performed using DNA microarrays, which showed that valine caused an increased ilvBN mRNA level in VAL1 but not in the wild type. This unexpected result was confirmed by an increased cellular level of the ilvB protein product, i.e., the large subunit of acetohydroxyacid synthase (AHAS), and by an increased AHAS activity of valine-treated VAL1 cells. The conclusion that valine caused the limitation of another branched-chain amino acid was confirmed by showing that high concentrations of L-isoleucine could relieve the valine effect on VAL1 whereas L-leucine had the same effect as valine. The valine-caused isoleucine limitation was supported by the finding that the inhibitory valine effect was linked to the ilvA deletion that results in isoleucine auxotrophy. Taken together, these results implied that the valine effect is caused by competition for uptake of isoleucine by the carrier BrnQ, which transports all branched-chained amino acids. Indeed, valine inhibition could also be relieved by supplementing VAL1 with the dipeptide isoleucyl-isoleucine, which is taken up by a dipeptide transport system rather than by BrnQ. Interestingly, addition of external valine stimulated valine production by VAL1. This effect is most probably due to a reduced carbon usage for biomass production and to the increased expression of ilvBN, indicating that AHAS activity may still be a limiting factor for valine production in the VAL1 strain.
000022962 536__ $$0G:(DE-Juel1)FUEK256$$2G:(DE-HGF)$$aBiotechnologie$$cL02$$x0
000022962 588__ $$aDataset connected to Web of Science
000022962 650_7 $$2WoSType$$aJ
000022962 7001_ $$0P:(DE-Juel1)VDB2832$$aRittmann, D.$$b1$$uFZJ
000022962 7001_ $$0P:(DE-Juel1)VDB1764$$aWendisch, V. F.$$b2$$uFZJ
000022962 7001_ $$0P:(DE-Juel1)128943$$aBott, M.$$b3$$uFZJ
000022962 7001_ $$0P:(DE-Juel1)128985$$aSahm, H.$$b4$$uFZJ
000022962 773__ $$0PERI:(DE-600)1478346-0$$a10.1128/AEM.69.5.2521-2532.2003$$gVol. 69, p. 2521 - 2532$$p2521 - 2532$$q69<2521 - 2532$$tApplied and environmental microbiology$$v69$$x0099-2240$$y2003
000022962 8567_ $$uhttp://hdl.handle.net/2128/2407$$uhttp://dx.doi.org/10.1128/AEM.69.5.2521-2532.2003
000022962 8564_ $$uhttps://juser.fz-juelich.de/record/22962/files/13981.pdf$$yOpenAccess
000022962 8564_ $$uhttps://juser.fz-juelich.de/record/22962/files/13981.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000022962 8564_ $$uhttps://juser.fz-juelich.de/record/22962/files/13981.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000022962 8564_ $$uhttps://juser.fz-juelich.de/record/22962/files/13981.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000022962 909CO $$ooai:juser.fz-juelich.de:22962$$pdnbdelivery$$pVDB$$pdriver$$popen_access$$popenaire
000022962 9131_ $$0G:(DE-Juel1)FUEK256$$bLeben$$kL02$$lBiotechnologie$$vBiotechnologie$$x0
000022962 9141_ $$y2003
000022962 915__ $$0StatID:(DE-HGF)0010$$aJCR/ISI refereed
000022962 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000022962 9201_ $$0I:(DE-Juel1)VDB55$$gIBT$$kIBT-1$$lBiotechnologie 1$$x0$$zab 31.10.10 weitergeführt als IBG-1
000022962 970__ $$aVDB:(DE-Juel1)13981
000022962 980__ $$aVDB
000022962 980__ $$aJUWEL
000022962 980__ $$aConvertedRecord
000022962 980__ $$ajournal
000022962 980__ $$aI:(DE-Juel1)IBG-1-20101118
000022962 980__ $$aUNRESTRICTED
000022962 980__ $$aFullTexts
000022962 9801_ $$aFullTexts
000022962 981__ $$aI:(DE-Juel1)IBG-1-20101118